Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
iQSTEL's revenue in October 2022 reached $9.4 million based on preliminary accounting. This represents an 83% increase over the $5.1 recorded in October 2021. This news already hit the market. The whole market is bleeding while IQST is still holding on!
https://www.globenewswire.com/news-release/2022/11/16/2557275/0/en/IQST-iQSTEL-Announces-83-Revenue-Increase-For-October-To-9-4M-After-Reporting-First-Profitable-Quarter-With-33-Revenue-Increase-To-21-94M.html
Sequire Spotlight Presents Precision Genomics - Ludwig (LUDG): Groundbreaking Medical Technology
Host Jonathan Miller interviews Chief Science Officer: Dr. Marvin Hausman. He teaches us how genetics, chromosomes, and mRNA, can provide an early diagnostic using their high-level technology, to alert patients who may be prone to high-risk illnesses & diseases.
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
IQST – iQSTEL Reaches Profitability Ahead Of Forecast On 33% Q3 Revenue Growth To $21.94M On Track To Meet Or Exceed $90M In Revenue By Yearend
•iQSTEL has become profitable in the third quarter of 2020, a significant milestone for the company.
• The third quarter report showed a 68% increase in gross profit and a 128% reduction in operating loss.
• iQSTEL is on track to meet or exceed its projected 90 million gross revenue forecast for 2021.
• Cost-cutting measures have helped to reduce operating expenses, while new contracts and partners have driven top-line growth.
• Once a company becomes profitable, it can reinvest its profits into growth initiatives such as marketing and new product development.
• Now iQSTEL further meets NASDAQ requirements and will soon be dual trading with Upstream allowing international investors to buy stock.
• The company had traded before as high as $1 to $2 a share and is certainly way undervalued at current prices as a profitable company.
https://www.canva.com/design/DAE9yR4H6xQ/VQ3V3hLq-SLbwY2v0i0Zkg/view?utm_content=DAE9yR4H6xQ&utm_campaign=designshare&utm_medium=link&utm_source=viewer
IQST – iQSTEL Reaches Profitability Ahead Of Forecast On 33% Q3 Revenue Growth To $21.94M On Track To Meet Or Exceed $90M In Revenue By Yearend
•iQSTEL has become profitable in the third quarter of 2020, a significant milestone for the company.
• The third quarter report showed a 68% increase in gross profit and a 128% reduction in operating loss.
• iQSTEL is on track to meet or exceed its projected 90 million gross revenue forecast for 2021.
• Cost-cutting measures have helped to reduce operating expenses, while new contracts and partners have driven top-line growth.
• Once a company becomes profitable, it can reinvest its profits into growth initiatives such as marketing and new product development.
• Now iQSTEL further meets NASDAQ requirements and will soon be dual trading with Upstream allowing international investors to buy stock.
• The company had traded before as high as $1 to $2 a share and is certainly way undervalued at current prices as a profitable company.
http://bit.ly/IQSTELFinancialEvolutionQ3_2022
IQST – iQSTEL Reaches Profitability Ahead Of Forecast On 33% Q3 Revenue Growth To $21.94M On Track To Meet Or Exceed $90M In Revenue By Yearend
•iQSTEL has become profitable in the third quarter of 2020, a significant milestone for the company.
• The third quarter report showed a 68% increase in gross profit and a 128% reduction in operating loss.
• iQSTEL is on track to meet or exceed its projected 90 million gross revenue forecast for 2021.
• Cost-cutting measures have helped to reduce operating expenses, while new contracts and partners have driven top-line growth.
• Once a company becomes profitable, it can reinvest its profits into growth initiatives such as marketing and new product development.
• Now iQSTEL further meets NASDAQ requirements and will soon be dual trading with Upstream allowing international investors to buy stock.
• The company had traded before as high as $1 to $2 a share and is certainly way undervalued at current prices as a profitable company.
http://bit.ly/IQSTELFinancialEvolutionQ3_2022
$CLIS - ClickStream Corp. announced that its Nifter NFT marketplace has launched an end-to-end production and distribution department designed to make it simple for artists to produce viral content and collect royalties for music and video-based NFTs.
With this launch, Nifter expands its revenue streams beyond the sale of NFTs and positions Nifter as a "one-stop-shop" for artists to produce quality content, record royalty splits with Nifter's Rebel Blockchain, as well as collect royalties for music distributed on Apple Music, Spotify, and other streaming platforms.
https://finance.yahoo.com/news/nifter-launches-production-arm-produce-122700873.html
$CLIS - ClickStream Corp. announced that its Nifter NFT marketplace has launched an end-to-end production and distribution department designed to make it simple for artists to produce viral content and collect royalties for music and video-based NFTs.
With this launch, Nifter expands its revenue streams beyond the sale of NFTs and positions Nifter as a "one-stop-shop" for artists to produce quality content, record royalty splits with Nifter's Rebel Blockchain, as well as collect royalties for music distributed on Apple Music, Spotify, and other streaming platforms.
https://finance.yahoo.com/news/nifter-launches-production-arm-produce-122700873.html
$CLIS - ClickStream Corp. announced that its Nifter NFT marketplace has launched an end-to-end production and distribution department designed to make it simple for artists to produce viral content and collect royalties for music and video-based NFTs.
With this launch, Nifter expands its revenue streams beyond the sale of NFTs and positions Nifter as a "one-stop-shop" for artists to produce quality content, record royalty splits with Nifter's Rebel Blockchain, as well as collect royalties for music distributed on Apple Music, Spotify, and other streaming platforms.
https://finance.yahoo.com/news/nifter-launches-production-arm-produce-122700873.html
$MLRT - MetAlert, Inc. announced that Canadian distributor Red Dot Alerts has launched the new award-winning 4G GPS SmartSole, a wearable medical monitoring device integrated into an orthotic insole allowing discreet tracking and remote monitoring of Alzheimer’s, dementia, and autism sufferers.
The product launch is supported by a marketing and advertising campaign, including radio ads, magazine ads, and mailers to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. Some of the ads were placed on BOOM Radio, CARP (Canadian Association for Retired People), Bruyère Foundation, and Magazine 55+ just to name a few. The advertising campaign will continue into spring 2023 to coincide with Canada’s Fall Prevention Month in November and Alzheimer’s Awareness Month in January.
This is a huge catalyst for growth for $MLRT and they are set to hit a spike soon.
https://finance.yahoo.com/news/metalert-distributor-red-dot-alerts-132200894.html
$MLRT - MetAlert, Inc. announced that Canadian distributor Red Dot Alerts has launched the new award-winning 4G GPS SmartSole, a wearable medical monitoring device integrated into an orthotic insole allowing discreet tracking and remote monitoring of Alzheimer’s, dementia, and autism sufferers.
The product launch is supported by a marketing and advertising campaign, including radio ads, magazine ads, and mailers to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. Some of the ads were placed on BOOM Radio, CARP (Canadian Association for Retired People), Bruyère Foundation, and Magazine 55+ just to name a few. The advertising campaign will continue into spring 2023 to coincide with Canada’s Fall Prevention Month in November and Alzheimer’s Awareness Month in January.
This is a huge catalyst for growth for $MLRT and they are set to hit a spike soon.
https://finance.yahoo.com/news/metalert-distributor-red-dot-alerts-132200894.html
$MLRT - MetAlert, Inc. announced that Canadian distributor Red Dot Alerts has launched the new award-winning 4G GPS SmartSole, a wearable medical monitoring device integrated into an orthotic insole allowing discreet tracking and remote monitoring of Alzheimer’s, dementia, and autism sufferers.
The product launch is supported by a marketing and advertising campaign, including radio ads, magazine ads, and mailers to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. Some of the ads were placed on BOOM Radio, CARP (Canadian Association for Retired People), Bruyère Foundation, and Magazine 55+ just to name a few. The advertising campaign will continue into spring 2023 to coincide with Canada’s Fall Prevention Month in November and Alzheimer’s Awareness Month in January.
This is a huge catalyst for growth for $MLRT and they are set to hit a spike soon.
https://finance.yahoo.com/news/metalert-distributor-red-dot-alerts-132200894.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$MLRT - MetAlert, Inc. is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution that includes hardware software connectivity all designed for seamless integration into consumer products as well enterprise applications with two-way GPS technology which enables subscribers to track people or high-value assets anywhere on earth via the miniaturized low-power consumption components enabled by the latest RF NFC BLE tech allowing them to monitor exactly where their loved ones are at any given time. With its cutting-edge technology and strong industry partnerships, MetAlert is a great stock for investors who are looking for long-term growth potential.
https://pubcoinsight.com/the-seven-best-performing-stocks-to-own-for-the-long-term/
$MLRT - MetAlert, Inc. is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution that includes hardware software connectivity all designed for seamless integration into consumer products as well enterprise applications with two-way GPS technology which enables subscribers to track people or high-value assets anywhere on earth via the miniaturized low-power consumption components enabled by the latest RF NFC BLE tech allowing them to monitor exactly where their loved ones are at any given time. With its cutting-edge technology and strong industry partnerships, MetAlert is a great stock for investors who are looking for long-term growth potential.
https://pubcoinsight.com/the-seven-best-performing-stocks-to-own-for-the-long-term/
$MLRT - MetAlert is a Los Angeles-based company focusing on consumer healthcare and medical technology products. Its flagship GPS SmartSole tracker is the perfect solution for the problem of wandering because it was made specifically for this purpose. The SmartSole is an insole for shoes that comes equipped with a GPS and cellular tracking device built into it. It is easy to conceal, and patients are less likely to forget their boots at home before they head out the door. This flagship product is a significant catalyst for growth for the company! It's better to do DD on $MLRT.
https://ritzherald.com/why-this-otc-company-has-a-better-solution-than-apples-air-tags/
$MLRT - MetAlert is a Los Angeles-based company focusing on consumer healthcare and medical technology products. Its flagship GPS SmartSole tracker is the perfect solution for the problem of wandering because it was made specifically for this purpose. The SmartSole is an insole for shoes that comes equipped with a GPS and cellular tracking device built into it. It is easy to conceal, and patients are less likely to forget their boots at home before they head out the door. This flagship product is a significant catalyst for growth for the company! It's better to do DD on $MLRT.
https://ritzherald.com/why-this-otc-company-has-a-better-solution-than-apples-air-tags/
•iQSTEL has become profitable in the third quarter of 2020, a significant milestone for the company.
• The third quarter report showed a 68% increase in gross profit and a 128% reduction in operating loss.
• iQSTEL is on track to meet or exceed its projected 90 million gross revenue forecast for 2021.
• Cost-cutting measures have helped to reduce operating expenses, while new contracts and partners have driven top-line growth.
• Once a company becomes profitable, it can reinvest its profits into growth initiatives such as marketing and new product development.
• Now iQSTEL further meets NASDAQ requirements and will soon be dual trading with Upstream allowing international investors to buy stock.
• The company had traded before as high as $1 to $2 a share and is certainly way undervalued at current prices as a profitable company.
https://www.globenewswire.com/news-release/2022/11/14/2555235/0/en/IQST-iQSTEL-Reaches-Profitability-Ahead-Of-Forecast-On-33-Q3-Revenue-Growth-To-21-94M-On-Track-To-Meet-Or-Exceed-90M-In-Revenue-By-Yearend.html
•iQSTEL has become profitable in the third quarter of 2020, a significant milestone for the company.
• The third quarter report showed a 68% increase in gross profit and a 128% reduction in operating loss.
• iQSTEL is on track to meet or exceed its projected 90 million gross revenue forecast for 2021.
• Cost-cutting measures have helped to reduce operating expenses, while new contracts and partners have driven top-line growth.
• Once a company becomes profitable, it can reinvest its profits into growth initiatives such as marketing and new product development.
• Now iQSTEL further meets NASDAQ requirements and will soon be dual trading with Upstream allowing international investors to buy stock.
• The company had traded before as high as $1 to $2 a share and is certainly way undervalued at current prices as a profitable company.
https://www.globenewswire.com/news-release/2022/11/14/2555235/0/en/IQST-iQSTEL-Reaches-Profitability-Ahead-Of-Forecast-On-33-Q3-Revenue-Growth-To-21-94M-On-Track-To-Meet-Or-Exceed-90M-In-Revenue-By-Yearend.html
•iQSTEL has become profitable in the third quarter of 2020, a significant milestone for the company.
• The third quarter report showed a 68% increase in gross profit and a 128% reduction in operating loss.
• iQSTEL is on track to meet or exceed its projected 90 million gross revenue forecast for 2021.
• Cost-cutting measures have helped to reduce operating expenses, while new contracts and partners have driven top-line growth.
• Once a company becomes profitable, it can reinvest its profits into growth initiatives such as marketing and new product development.
• Now iQSTEL further meets NASDAQ requirements and will soon be dual trading with Upstream allowing international investors to buy stock.
• The company had traded before as high as $1 to $2 a share and is certainly way undervalued at current prices as a profitable company.
https://www.globenewswire.com/news-release/2022/11/14/2555235/0/en/IQST-iQSTEL-Reaches-Profitability-Ahead-Of-Forecast-On-33-Q3-Revenue-Growth-To-21-94M-On-Track-To-Meet-Or-Exceed-90M-In-Revenue-By-Yearend.html
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$CLIS - ClickStream Corp. has begun the adoption of Polygon/MATIC to lower transaction costs for the minting of NFTs and extend the usefulness beyond just art. Adopting Polygon allows Nifter™ to use NFTs as events tickets, memorabilia trade-ins, content royalty tracking, and other revenue streams that are a part of Nifter's revenue strategy.
https://finance.yahoo.com/news/nifter-begins-cross-chain-adoption-123800904.html
$CLIS - ClickStream Corp. has begun the adoption of Polygon/MATIC to lower transaction costs for the minting of NFTs and extend the usefulness beyond just art. Adopting Polygon allows Nifter™ to use NFTs as events tickets, memorabilia trade-ins, content royalty tracking, and other revenue streams that are a part of Nifter's revenue strategy.
https://finance.yahoo.com/news/nifter-begins-cross-chain-adoption-123800904.html
$CLIS - ClickStream Corp. has begun the adoption of Polygon/MATIC to lower transaction costs for the minting of NFTs and extend the usefulness beyond just art. Adopting Polygon allows Nifter™ to use NFTs as events tickets, memorabilia trade-ins, content royalty tracking, and other revenue streams that are a part of Nifter's revenue strategy.
https://finance.yahoo.com/news/nifter-begins-cross-chain-adoption-123800904.html
$SFLM - SFLMaven recently announced the launch of its second line of NFTs in the Decentraland Metaverse. It is also working on developing a new novel technology that displays the value of an NFT along with the avatar in any Metaverse environment. SLFMaven started as a vintage jewelry store on eBay that still does over $1 million in sales each month. SFLMaven’s next line of NFTs is believed to be launching in Decentraland in the new year.
https://pubcoinsight.com/moncler-is-the-latest-fashion-brand-to-join-the-metaverse
$SFLM - SFLMaven recently announced the launch of its second line of NFTs in the Decentraland Metaverse. It is also working on developing a new novel technology that displays the value of an NFT along with the avatar in any Metaverse environment. SLFMaven started as a vintage jewelry store on eBay that still does over $1 million in sales each month. SFLMaven’s next line of NFTs is believed to be launching in Decentraland in the new year.
https://pubcoinsight.com/moncler-is-the-latest-fashion-brand-to-join-the-metaverse
$SFLM - SFLMaven recently announced the launch of its second line of NFTs in the Decentraland Metaverse. It is also working on developing a new novel technology that displays the value of an NFT along with the avatar in any Metaverse environment. SLFMaven started as a vintage jewelry store on eBay that still does over $1 million in sales each month. SFLMaven’s next line of NFTs is believed to be launching in Decentraland in the new year.
https://pubcoinsight.com/moncler-is-the-latest-fashion-brand-to-join-the-metaverse
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG